Search

Your search keyword '"Pharoah, P.D.P. (Paul)"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Pharoah, P.D.P. (Paul)" Remove constraint Author: "Pharoah, P.D.P. (Paul)"
61 results on '"Pharoah, P.D.P. (Paul)"'

Search Results

1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

2. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

3. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement (Nature Reviews Clinical Oncology, (2020), 10.1038/s41571-020-0388-9)

4. Personalized early detection and prevention of breast cancer: ENVISION consensus statement

5. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

6. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

7. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

8. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

9. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

10. Body mass index and breast cancer survival

11. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

12. Reproductive profiles and risk of breast cancer subtypes

13. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

14. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

15. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

16. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

17. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

18. Prognostic value of automated KI67 scoring in breast cancer: A centralised evaluation of 8088 patients from 10 study groups

19. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (BCAC)

20. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

21. Genetic predisposition to ductal carcinoma in situ of the breast

22. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

23. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

24. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

25. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

26. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

27. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

28. Prediction of breast cancer risk based on profiling with common genetic variants

29. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

30. Identification of novel genetic markers of breast cancer survival

31. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

32. Common germline polymorphisms associated with breast cancer-specific survival

33. Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis

34. Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

35. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

36. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

37. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

38. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: A case-control study

39. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

40. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

41. MicroRNA related polymorphisms and breast cancer risk

42. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

43. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

44. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

45. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

46. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

47. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

48. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium

49. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

50. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

Catalog

Books, media, physical & digital resources